Literature DB >> 11135618

Isolation of primary HIV-1 that target CD8+ T lymphocytes using CD8 as a receptor.

K Saha1, J Zhang, A Gupta, R Dave, M Yimen, B Zerhouni.   

Abstract

HIV-1 use CD4 receptors to infect their primary targets, CD4+ cells, whereas CD8+ cells have a protective role against HIV-1. We recently isolated HIV-1-producing CD8+ clones from two AIDS patients. Here we show that although HIV-1 produced by CD8+ cells maintained the ability to infect CD4+ cells, these viruses were able to infect CD8+ cells independent of CD4. Evidence indicates that these viruses used CD8 as a receptor to infect CD8+ cells. First, expression of CD8 was downmodulated after infection. Second, anti-CD8 antibodies blocked viral entry and replication in CD8+ cells. Finally, resistant cells became susceptible after expression of CD8. Although these viruses used CXCR4 to enter CD4+ cells, it seems that infection of CD8+ cells was independent of CXCR4 or CCR5 co-receptors. Novel changes were observed in envelope sequences of CD8-tropic viruses. These results provide initial evidence that HIV-1 can mutate to infect CD8+ cells using CD8 as a receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135618     DOI: 10.1038/83365

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  24 in total

1.  Animal studies and HIV research.

Authors:  Ray Greek; Pandora Pound
Journal:  BMJ       Date:  2002-01-26

2.  Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.

Authors:  G V Ramana; A Vasanthi; M Khaja; B Su; V Govindaiah; L Jin; L Singh; R Chakraborty
Journal:  J Genet       Date:  2001-12       Impact factor: 1.166

3.  Highly uneven distribution of tenofovir-selected simian immunodeficiency virus in different anatomical sites of rhesus macaques.

Authors:  Magdalena Magierowska; Flavien Bernardin; Seema Garg; Silvija Staprans; Michael D Miller; Koen K A Van Rompay; Eric L Delwart
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

4.  Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins.

Authors:  Anke Heigele; Michael Schindler; Clement W Gnanadurai; Jolie A Leonard; Kathleen L Collins; Frank Kirchhoff
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

5.  HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements.

Authors:  Jolie A Leonard; Tracy Filzen; Christoph C Carter; Malinda Schaefer; Kathleen L Collins
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  Distribution of HIV-1 infection in different T lymphocyte subsets: antiretroviral therapy-naïve vs. experienced patients.

Authors:  Raul Perez; Sonia Gibson; Pablo Lopez; Ellen Koenig; Marisol De Castro; Yasuhiro Yamamura
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-07       Impact factor: 2.205

7.  High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.

Authors:  Alexandra Cochrane; Stuart Imlach; Clifford Leen; Gordon Scott; Dermot Kennedy; Peter Simmonds
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Could CD4 capture by CD8+ T cells play a role in HIV spreading?

Authors:  Anne Aucher; Isabel Puigdomènech; Etienne Joly; Bonaventura Clotet; Denis Hudrisier; Julià Blanco
Journal:  J Biomed Biotechnol       Date:  2010-03-25

9.  T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.

Authors:  Jason M Brenchley; Brenna J Hill; David R Ambrozak; David A Price; Francisco J Guenaga; Joseph P Casazza; Janaki Kuruppu; Javaidia Yazdani; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Isolation of CD4-independent primary human immunodeficiency virus type 1 isolates that are syncytium inducing and acutely cytopathic for CD8+ lymphocytes.

Authors:  Bouchra Zerhouni; Julie A E Nelson; Kunal Saha
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.